PDL BioPharma to Present at Upcoming Investor Conferences

06 Sep, 2012, 16:00 ET from PDL BioPharma, Inc.

INCLINE VILLAGE, Nev., Sept. 6, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the following upcoming conferences.

(Logo:  http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

Rodman and Renshaw Annual Global Investment Conference Tuesday, September 11, 2012 11:40 a.m. ET New York City

G9: ThinkEquity's 9th Annual Growth Conference Thursday, September 13, 2012 10:30 a.m. ET New York City

UBS Global Life Sciences Conference Wednesday, September 19, 2012 11:30 a.m. ET New York City

To access the live and subsequently archived webcasts of the presentations, go to the Company's website at http://www.pdl.com and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following each presentation.

About PDL BioPharma PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing the value of its patent portfolio and related assets. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.



RELATED LINKS

http://www.pdl.com